Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
53.8M
-
Shares change
-
+1.54M
-
Total reported value, excl. options
-
$555M
-
Value change
-
-$2.77M
-
Put/Call ratio
-
0.38
-
Number of buys
-
48
-
Number of sells
-
-39
-
Price
-
$10.30
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q3 2023
126 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q3 2023.
AVADEL PHARMACEUTICALS - COM (AVDL) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.8M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (10.6M shares), RTW INVESTMENTS, LP (7.14M shares), GENDELL JEFFREY L (5.62M shares), Polar Capital Holdings Plc (4.51M shares), Vivo Capital, LLC (4.1M shares), WEALTH EFFECTS LLC (2.41M shares), COWEN AND COMPANY, LLC (2.34M shares), Woodline Partners LP (1.9M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.73M shares), and BRANDES INVESTMENT PARTNERS, LP (1.45M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.